MDT
44
5
COST
69
-4
LLY
73
-3
KLAC
65
-2
BAC
44
-4
WHR
57
2
GPS
57
-3
GME
59
-6
MUR
26
-3
ALL
45
-3
AMP
73
-2
SRE
30
-2
FOX
30
2
BBY
55
-2
LYB
32
2
GS
65
2
NOV
37
-2
RHI
43
15
BMY
43
8
RIG
28
2
MDT
44
5
COST
69
-4
LLY
73
-3
KLAC
65
-2
BAC
44
-4
WHR
57
2
GPS
57
-3
GME
59
-6
MUR
26
-3
ALL
45
-3
AMP
73
-2
SRE
30
-2
FOX
30
2
BBY
55
-2
LYB
32
2
GS
65
2
NOV
37
-2
RHI
43
15
BMY
43
8
RIG
28
2
Financhill
Back

South Plains Financial Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
39

SPFI
South Plains Financial

Last Price:
26.04
Seasonality Move:
5.49%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
39
South Plains Financial (SPFI) is a Sell

Is South Plains Financial a Buy, Sell or Hold?

  • The current South Plains Financial [SPFI] share price is $26.17. The Score for SPFI is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • SPFI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPFI Stock Price Chart

What is South Plains Financial's stock price today?

  • The South Plains Financial share price today is $26.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPFI is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

SPFI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 47.82 Sell
Chaikin Money Flow: 32121 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.95 - 27.19) Sell
Bollinger Bands (100): (25.45 - 27.01) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

SPFI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.04 Buy
20-day SMA: 26.34 Sell
50-day SMA: 26.46 Sell
200-day SMA: 26.74 Sell
8-day EMA: 26.14 Buy
20-day EMA: 26.32 Sell
50-day EMA: 26.42 Sell
200-day EMA: 26.38 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

South Plains Financial Earnings Growth & SPFI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.12 per share, and an increase next year of $0.14 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

South Plains Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):